Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127581011 | 12758101 | 1 | I | 20150529 | 20160905 | 20160919 | 20160919 | EXP | FR-AUROBINDO-AUR-APL-2016-11397 | AUROBINDO | 85.60 | YR | M | Y | 0.00000 | 20160919 | CN | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127581011 | 12758101 | 1 | PS | Paroxetine Arrow | PAROXETINE | 1 | Oral | 1 DF, ONCE A DAY | D | U | 78406 | 1 | DF | QD | |||||
| 127581011 | 12758101 | 2 | SS | COUMADINE | WARFARIN SODIUM | 1 | Oral | 0.75 DF, ONCE A DAY | D | U | 0 | .75 | DF | QD | |||||
| 127581011 | 12758101 | 3 | C | AZILECT | RASAGILINE MESYLATE | 1 | Unknown | 1 MG, UNK | U | 0 | 1 | MG | TABLET | ||||||
| 127581011 | 12758101 | 4 | C | LASILIX /00032601/ | FUROSEMIDE | 1 | Unknown | U | 0 | TABLET | |||||||||
| 127581011 | 12758101 | 5 | C | MODOPAR | BENSERAZIDE HYDROCHLORIDELEVODOPA | 1 | Unknown | U | 0 | ||||||||||
| 127581011 | 12758101 | 6 | C | TRANSIPEG /00754501/ | POLYETHYLENE GLYCOL 3350 | 1 | Unknown | U | 0 | POWDER FOR ORAL SOLUTION | |||||||||
| 127581011 | 12758101 | 7 | C | XATRAL | ALFUZOSIN | 1 | Unknown | 10 MG, UNK | U | 0 | 10 | MG | PROLONGED-RELEASE TABLET | ||||||
| 127581011 | 12758101 | 8 | C | PANTOPRAZOLE | PANTOPRAZOLE SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 127581011 | 12758101 | 9 | C | AVODART | DUTASTERIDE | 1 | Unknown | U | 0 | CAPSULE, SOFT | |||||||||
| 127581011 | 12758101 | 10 | C | DOLIPRANE | ACETAMINOPHEN | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127581011 | 12758101 | 1 | Product used for unknown indication |
| 127581011 | 12758101 | 2 | Product used for unknown indication |
| 127581011 | 12758101 | 3 | Product used for unknown indication |
| 127581011 | 12758101 | 4 | Product used for unknown indication |
| 127581011 | 12758101 | 5 | Product used for unknown indication |
| 127581011 | 12758101 | 6 | Product used for unknown indication |
| 127581011 | 12758101 | 7 | Product used for unknown indication |
| 127581011 | 12758101 | 8 | Product used for unknown indication |
| 127581011 | 12758101 | 9 | Product used for unknown indication |
| 127581011 | 12758101 | 10 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127581011 | 12758101 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127581011 | 12758101 | Anaemia | |
| 127581011 | 12758101 | Cardio-respiratory arrest | |
| 127581011 | 12758101 | Gastrointestinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127581011 | 12758101 | 1 | 201505 | 0 | ||
| 127581011 | 12758101 | 2 | 20150529 | 0 |